73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Removing binding sites for an oncogene can slow down cancer cell growth

Removing binding sites for an oncogene can slow down cancer cell growth

byUniversity of HelsinkiStrategy of the CGE method to lineage-trace cells with distinct genome editing events using sequence tags with silent or near-silent mutations. a, The CGE method uses a l

Removing binding sites for an oncogene can slow down cancer cell growth

byUniversity of HelsinkiStrategy of the CGE method to lineage-trace cells with distinct genome editing events using sequence tags with silent or near-silent mutations. a, The CGE method uses a l
Costs of $259,324 incurred by adolescent, young adult cancer survivors

Costs of $259,324 incurred by adolescent, young adult cancer survivors

by Elana GotkineAdolescent and young adult (AYA) cancer survivors incur costs of $259,324 over their lifetime, according to a study published online Feb. 24 in theJournal of Clinical Oncology.Su

Costs of $259,324 incurred by adolescent, young adult cancer survivors

by Elana GotkineAdolescent and young adult (AYA) cancer survivors incur costs of $259,324 over their lifetime, according to a study published online Feb. 24 in theJournal of Clinical Oncology.Su
Efficacy shown for new melanoma therapeutic vaccine

Efficacy shown for new melanoma therapeutic vaccine

by Physician's Briefing StaffIn a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly

Efficacy shown for new melanoma therapeutic vaccine

by Physician's Briefing StaffIn a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly
Enhanced treatment of liver carcinoma with a drug-eluting hydrogel

Enhanced treatment of liver carcinoma with a drug-eluting hydrogel

by Stewart Han, Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with

Enhanced treatment of liver carcinoma with a drug-eluting hydrogel

by Stewart Han, Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with
Cherenkov color imaging shows promise in enhancing radiation therapy effectiveness

Cherenkov color imaging shows promise in enhancing radiation therapy effectiveness

bySPIEA three-channel camera separates Cherenkov emissions into red, green, and blue channels, allowing the investigation of the impact of variations in melanin and blood levels on the signal. T

Cherenkov color imaging shows promise in enhancing radiation therapy effectiveness

bySPIEA three-channel camera separates Cherenkov emissions into red, green, and blue channels, allowing the investigation of the impact of variations in melanin and blood levels on the signal. T
Link between sphingolipids and complement signaling may be key to stopping cancer metastasis

Link between sphingolipids and complement signaling may be key to stopping cancer metastasis

by Caroline Wallace,Medical University of South CarolinaGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111742MUSC Hollings Cancer Center researchers have i

Link between sphingolipids and complement signaling may be key to stopping cancer metastasis

by Caroline Wallace,Medical University of South CarolinaGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111742MUSC Hollings Cancer Center researchers have i
Strong family history of prostate cancer linked to better survival

Strong family history of prostate cancer linked to better survival

byInstitute of Cancer ResearchAll-cause mortality among PrCa patients, by (A) the number of affected relatives and (B) degree of FH of the affected relatives. Deg.=degree; FH=&

Strong family history of prostate cancer linked to better survival

byInstitute of Cancer ResearchAll-cause mortality among PrCa patients, by (A) the number of affected relatives and (B) degree of FH of the affected relatives. Deg.=degree; FH=&
Supercharging immunotherapy to stop breast cancer from spreading to the lung

Supercharging immunotherapy to stop breast cancer from spreading to the lung

byUniversity of GlasgowGraphical abstract. Credit:Journal of Experimental Medicine(2022). DOI: 10.1084/jem.20211431Breast cancer immunotherapy could be more effective if an immune ce

Supercharging immunotherapy to stop breast cancer from spreading to the lung

byUniversity of GlasgowGraphical abstract. Credit:Journal of Experimental Medicine(2022). DOI: 10.1084/jem.20211431Breast cancer immunotherapy could be more effective if an immune ce
Potential new series of drugs targeting cancer-driving protein BCL6

Potential new series of drugs targeting cancer-driving protein BCL6

byInstitute of Cancer ResearchThe BCL6 BTB domain dimer (in grey/green) and compound hits in pink, superimposed on each other in the main compound binding site. Credit: Dr Rob van Montfort lab /

Potential new series of drugs targeting cancer-driving protein BCL6

byInstitute of Cancer ResearchThe BCL6 BTB domain dimer (in grey/green) and compound hits in pink, superimposed on each other in the main compound binding site. Credit: Dr Rob van Montfort lab /
Potential melanoma target bypasses therapeutic resistance to immune checkpoint blockers

Potential melanoma target bypasses therapeutic resistance to immune checkpoint blockers

by Jeff Hansen,University of Alabama at BirminghamConstitutive activation of JAK1/2 in IFNγR1KOmelanoma cells. a Identification of a JAK1/2-centric network of activated protein tyrosine ki

Potential melanoma target bypasses therapeutic resistance to immune checkpoint blockers

by Jeff Hansen,University of Alabama at BirminghamConstitutive activation of JAK1/2 in IFNγR1KOmelanoma cells. a Identification of a JAK1/2-centric network of activated protein tyrosine ki
Prostate tumor biology may be influenced by genetic ancestry

Prostate tumor biology may be influenced by genetic ancestry

byAmerican Association for Cancer ResearchSample collection sites and genetic admixture analysis. A, At clinical sites across Nigeria, 45 samples were collected. B, Admixture v1.3.0 was used to

Prostate tumor biology may be influenced by genetic ancestry

byAmerican Association for Cancer ResearchSample collection sites and genetic admixture analysis. A, At clinical sites across Nigeria, 45 samples were collected. B, Admixture v1.3.0 was used to